Compare
Lifeloc Technologies, Inc vs Scientific Industries Inc vs Precipio, Inc. vs Bionano Genomics, Inc.
| Latest fiscal year | Lifeloc Technologies, Inc LCTC | Scientific Industries Inc SCND | Precipio, Inc. PRPO | Bionano Genomics, Inc. BNGO |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $9.03M | $5.05M | $24.05M | $28.51M |
| Revenue growth (YoY) | +5.7% | +5.4% | +29.8% | -7.4% |
| Gross margin | 40.3% | 25.8% | 44.5% | 46.3% (computed) |
| Operating margin | -13.6% | -156.1% | -5.0% | -116.9% |
| Net margin | -27.4% | -24.1% | -1.5% | -92.6% |
| Net income | -$2.47M | -$1.22M | -$363.0K | -$26.39M |
| EPS (Diluted) | -$0.90 | -$0.11 | -$0.23 | -$4.85 |
| Operating cash flow | -$499.3K | -$8.15M | $685.0K | -$16.34M |
| Free cash flow | -$962.1K | -$8.21M | $359.0K | n/a |
| Cash & equivalents | n/a | n/a | $2.65M | $2.99M |
| Total assets | $6.69M | $12.61M | $21.32M | $73.58M |
| Total liabilities | $2.58M | $1.94M | $6.76M | $29.16M |
| Shareholders' equity | $4.10M | $10.66M | $14.56M | $44.42M |
| Return on year-end equity | -60.2% | -11.4% | -2.5% | -59.4% |
| Shares outstanding | 2.75M | 11.93M | 1.78M | 10.74M |
Revenue, most recent five fiscal years
| Fiscal year | Lifeloc Technologies, Inc | Scientific Industries Inc | Precipio, Inc. | Bionano Genomics, Inc. |
|---|---|---|---|---|
| Latest | $9.03M Ended 2025-12-31 | $5.05M Ended 2025-12-31 | $24.05M Ended 2025-12-31 | $28.51M Ended 2025-12-31 |
| 1 year earlier | $8.54M Ended 2024-12-31 | $4.80M Ended 2024-12-31 | $18.53M Ended 2024-12-31 | $30.78M Ended 2024-12-31 |
| 2 years earlier | $9.33M Ended 2023-12-31 | $11.11M Ended 2023-12-31 | $15.20M Ended 2023-12-31 | $36.12M Ended 2023-12-31 |
| 3 years earlier | $8.48M Ended 2022-12-31 | n/a | $9.41M Ended 2022-12-31 | $27.80M Ended 2022-12-31 |
| 4 years earlier | $7.05M Ended 2021-12-31 | n/a | $8.85M Ended 2021-12-31 | $17.98M Ended 2021-12-31 |